Frösler, H. M., Mancapa, N. R., Catenacci, L., Sorrenti, M., Bonferoni, M. C., & Caira, M. R. (2025). Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer. Pharmaceutics, 17(7), 842-860. https://doi.org/10.3390/pharmaceutics17070842
Citácia podle Chicago (17th ed.)Frösler, Hannah M., Neo Refiloe Mancapa, Laura Catenacci, Milena Sorrenti, Maria Cristina Bonferoni, a Mino R. Caira. "Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer." Pharmaceutics 17, no. 7 (2025): 842-860. https://doi.org/10.3390/pharmaceutics17070842.
Citácia podľa MLA (8th ed.)Frösler, Hannah M., et al. "Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer." Pharmaceutics, vol. 17, no. 7, 2025, pp. 842-860, https://doi.org/10.3390/pharmaceutics17070842.